Pinnacle Wealth Planning Services’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Hold
16,092
0.03% 322
2026
Q1
$223K Sell
16,092
-1,431
-8% -$22.8K 0.02% 438
2025
Q4
$285K Sell
17,523
-1,639
-9% -$26.7K 0.03% 345
2025
Q3
$287K Sell
19,162
-2,126
-10% -$25.9K 0.03% 335
2025
Q2
$248K Buy
21,288
+6,965
+49% +$63.3K 0.03% 351
2025
Q1
$106K Hold
14,323
0.02% 381
2024
Q4
$85.9K Sell
14,323
-18,920
-57% -$104K 0.01% 375
2024
Q3
$170K Hold
33,243
0.02% 476
2024
Q2
$120K Buy
33,243
+18,805
+130% +$59.7K 0.02% 469
2024
Q1
$46.3K Buy
+14,438
New +$55.9K 0.01% 505
2021
Q1
Sell
-2,238
Closed -$132K 365
2020
Q4
$132K Buy
+2,238
New +$115K 0.03% 379

Other funds holding ADPT

Pinnacle Wealth Planning Services's ADPT Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 16,092 shares worth $345K. The position accounts for 0.03% of the portfolio, ranked #322.

Pinnacle Wealth Planning Services first reported a position in ADPT in Q4 2020 and has held it in 11 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Pinnacle Wealth Planning Services held 16,092 shares of Adaptive Biotechnologies worth $345K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up 0.03% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #322 holding.
  • Pinnacle Wealth Planning Services first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 11 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.